PLK1 and neuroblastoma: In the present study, we have evaluated and screened the efficacy of the NF-kB/mTOR dual inhibitor 13-197, PLK1 inhibitor BI2536 and hedgehog pathway inhibitor vismodegib alone or in combination with topotecan against neuroblastoma.